Vanguard AG

Sustainability, economy, safety

Medical remanufacturing restores a used medical device to “as new” functional and safety standards. Medical remanufacturing enables circular economy within the healthcare sector. Products remanufactured by Vanguard AG help to make hospitals and clinics more resource-efficient while keeping their costs low, without compromising on safety or performance.


Vanguard AG extends the product life cycle of a single-use medical device and enables a more sustainable future for the medical device sector. Giving new life to your single-use devices, we protect the planet and its valuable resources.

Learn more


With Vanguard AG as your partner, the pursuit of sustainability pays off. There are no additional costs involved; in fact, medical remanufacturing can lead to cost savings of up to 50 percent.

Learn more


Using certified, state-of-the-art processes, Vanguard AG is global standard setter in medical remanufacturing. We ensure that remanufactured medical devices are restored to “as new” functional and safety standards and fully comply with all EU regulatory requirements.

Learn more

Vanguard AG is a European medical remanufacturer

Vanguard AG is a European medical remanufacturer based in Berlin. Since its foundation in 1998, Vanguard has pursued the goal of enabling the circular economy for complex medical devices.

For over 20 years, Vanguard AG has been setting global standards for medical remanufacturing, empowering healthcare institutions to operate more sustainably.

Offering sophisticated and environmentally-friendly product solutions, Vanguard AG uses innovative and certified medical remanufacturing processes. With its advanced technology, superior quality and expertise, Vanguard AG has established itself as a market leader in Europe. The remanufacturing of cooled ablation catheters and catheters with 3D mapping systems is one of our specialties.

Vanguard AG

20 years

as a market leader in remanufacturing.

1000 customers

university clinics, hospitals and manufacturers across Europe.

275 tons

medical waste avoided.

59340 kg CO2

p.a. saved by remanufacturing single-use-devices.

50 %

savings by remanufacturing instead of buying of new devices.


The AMDR (Association for Medical Remanufacturers) is a trade association founded in 1997, that represents the interests of the medical remanufacturing industry globally by emphasising the importance of high quality standards, waste reduction and healthcare cost reduction.

Learn more

Legal Framework

Here you can find out whether medical remanufacturing is permitted in your country and what conditions may apply.

Learn more

Management & Board

Marcus Bracklo (CEO)

Marcus H. Bracklo is the CEO of Vanguard AG. He has been a director of Vanguard AG since 2008, from 2008 to 2011 as a non executive director, from 2011 to 2015 as CEO, from 2015 to 2018 as non executive director and since 2018 again as CEO. Before joining Vanguard AG he founded the consulting and investment company Baigo Capital GmbH which has been a shareholder in Vanguard AG since 2008. Marcus Bracklo has a degree from the London School of Economics and aubsequently worked at the OECD in Paris. He qualified as a Chartered Accountant and Wirtschaftsprüfer and became a Partner at Price Waterhouse. His subsequent positions were: Partner and Head of the European Healthcare Corporate Finance Group of Arthur Andersen, Managing Director at Sal. Oppenheim where he founded the Healthcare Investment Banking Group which he led for many years. Marcus Bracklo has been active in the healthcare sector for over 30 years. Marcus Bracklo is non executive director of EuroEyes International Eye Clinic Ltd in Hong Kong and non executive chairman of the healthcare consulting firm Lohfert AG in Hamburg.



Supervisory Board

Wolfgang Boorberg (Chairman)

Wolfgang Boorberg is an auditor, tax consultant and legal counsellor for civil, commercial and corporate law. He is self-employed, working as a consultant for medium-sized companies. He is also the managing director and senior partner of Boorberg GmbH. He holds positions on various supervisory and advisory boards.


Dr Ulrich Wandschneider

Dr. Ulrich Wandschneider is a business consultant and a non executive director of several companies in the Lifescience and Healthcare Sector – some publicly quoted and subject to coedtermination. From 1987 to 2004 he worked for the consulting firms Arthur Andersen and Deloitte, the last seven years as partner. From 2004 to 2019 he was first CEO and from 2012 non executive chairman of MediClin AG. Additionally he was appointed CEO and later executive Chairman of the Asklepios Hospital Group from November 2011 until September 2018.


Ulrike Marczak

Ulrike Marczak gained a degree in industrial engineering from the Fachhochschule Stralsund. She held management positions at Biomet from 2000 to 2009, before joining the Vanguard AG in April of 2009. From 2009 to 2013, Marczak held various positions at the company, most recently head of operations. Since 2013, she has been the managing director of Angiokard Medizintechnik GmbH.